FDS vs TRU vs MORN
161 measures in 16 categories, one definition each, computed from filings and market data.
FDS66.1
FactSet Research Systems Inc.
Financial Services · Financial - Data & Stock Exchanges
$301.67 −0.05%$10.7B mkt cap
Score DNA
TRU68.5
TransUnion
Financial Services · Financial - Data & Stock Exchanges
$74.08 −0.05%$14.2B mkt cap
Score DNA
MORN69.1
Morningstar, Inc.
Financial Services · Financial - Data & Stock Exchanges
$207.37 −0.89%$7.8B mkt cap
Score DNA
Price, rebased to 100 three years ago
FDS TRU MORN · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | FDS | TRU | MORN |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 0 | 0 |
| Insider $ bought, 180d | — | — | — |
| Congress purchases, 180d | 0 | 0 | 0 |
| Last Congress purchase | — | — | — |
| 13F net change in holders | +46 | −39 | −28 |
| ETFs adding shares, 30d | 538 | 549 | 277 |
| ETFs trimming, 30d | 575 | 405 | 204 |
| Net ETF funds, 30d | −37 | +144 | +73 |
Valuation
16 measures| Measure | FDS | TRU | MORN |
|---|---|---|---|
| P/E (TTM) | 20.1x
22nd
|
16.7x
0th
|
18.5x
11th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | 2.68
89th
|
0.31
11th
|
0.11
0th
|
| Price / sales | 4.3x
20th
|
2.9x
0th
|
3.0x
10th
|
| Price / book | 5.4x
78th
|
2.9x
0th
|
7.6x
89th
|
| Price / tangible book | — | — | — |
| Price / free cash flow | 15.2x
0th
|
18.0x
30th
|
15.6x
10th
|
| Price / operating cash flow | 13.0x
20th
|
12.9x
10th
|
12.0x
0th
|
| Enterprise value | $12.0B
20th
|
$19.0B
30th
|
$9.2B
10th
|
| EV / sales | 4.8x
20th
|
3.9x
10th
|
3.6x
0th
|
| EV / EBITDA | 13.1x
22nd
|
10.4x
0th
|
11.3x
11th
|
| EV / EBIT | 17.1x
22nd
|
15.5x
11th
|
14.9x
0th
|
| EV / free cash flow | 17.0x
10th
|
24.1x
50th
|
18.4x
30th
|
| Earnings yield | 5.0%
80th
|
6.0%
100th
|
5.4%
90th
|
| FCF yield | 6.6%
100th
|
5.6%
70th
|
6.4%
90th
|
| Operating cash flow yield | 7.7%
80th
|
7.8%
90th
|
8.3%
100th
|
| Graham number (per share) | $137.80
75th
|
$49.62
25th
|
$81.79
50th
|
Profitability (TTM)
12 measures| Measure | FDS | TRU | MORN |
|---|---|---|---|
| Gross margin | 50.6%
10th
|
55.8%
20th
|
62.2%
40th
|
| EBITDA margin | 37.0%
40th
|
37.4%
50th
|
31.6%
20th
|
| Operating margin | 28.3%
40th
|
22.1%
20th
|
23.5%
30th
|
| EBIT margin | 28.4%
40th
|
25.0%
30th
|
23.9%
20th
|
| Net margin | 21.5%
30th
|
17.3%
20th
|
16.4%
10th
|
| NOPAT margin | 23.2%
40th
|
20.6%
30th
|
17.7%
20th
|
| FCF margin | 28.6%
30th
|
16.1%
0th
|
19.4%
10th
|
| Operating cash flow margin | 33.2%
30th
|
22.5%
0th
|
25.2%
10th
|
| R&D / revenue | 0.0%
0th
|
0.0%
0th
|
0.0%
0th
|
| SG&A / revenue | 22.3%
50th
|
27.5%
80th
|
32.2%
90th
|
| Stock comp / revenue | 3.4%
70th
|
2.3%
60th
|
2.2%
50th
|
| Effective tax rate | 17.9%
20th
|
6.6%
0th
|
25.0%
90th
|
Returns on capital
11 measures| Measure | FDS | TRU | MORN |
|---|---|---|---|
| ROE (on average equity) | 25.5%
78th
|
18.1%
56th
|
32.0%
89th
|
| ROA | 12.6%
70th
|
7.3%
40th
|
11.1%
60th
|
| ROIC | 17.5%
70th
|
10.4%
20th
|
18.8%
80th
|
| ROCE | 23.0%
80th
|
11.1%
40th
|
20.7%
70th
|
| Return on tangible assets | 16.6%
80th
|
10.5%
50th
|
16.2%
70th
|
| Cash ROIC (OCF / invested capital) | 25.1%
60th
|
11.4%
0th
|
26.9%
70th
|
| Gross profitability (GP / assets) | 30.2%
70th
|
22.4%
60th
|
40.5%
90th
|
| ROIC, 3-yr average | 16.4%
60th
|
4.5%
0th
|
15.3%
50th
|
| ROIC, 5-yr average | 19.5%
67th
|
7.3%
11th
|
14.2%
56th
|
| ROE, 5-yr average | 28.2%
89th
|
12.2%
33rd
|
20.0%
67th
|
| Incremental ROIC | -42.1%
40th
|
81.9%
70th
|
53.5%
60th
|
Growth
17 measures| Measure | FDS | TRU | MORN |
|---|---|---|---|
| Revenue growth (TTM YoY) | 6.7%
40th
|
12.4%
100th
|
9.3%
60th
|
| Revenue growth (QoQ) | 1.9%
50th
|
5.1%
90th
|
2.9%
70th
|
| Revenue CAGR, 3 yr | 5.9%
10th
|
9.3%
40th
|
10.0%
50th
|
| Revenue CAGR, 5 yr | 9.2%
50th
|
11.7%
70th
|
10.7%
60th
|
| Gross profit CAGR, 3 yr | 4.1%
10th
|
5.4%
20th
|
13.2%
60th
|
| Operating income CAGR, 3 yr | 3.6%
11th
|
20.5%
56th
|
69.6%
100th
|
| Net income growth (TTM YoY) | -10.6%
0th
|
116.4%
100th
|
4.3%
22nd
|
| Net income CAGR, 3 yr | 4.4%
11th
|
54.0%
89th
|
164.4%
100th
|
| EPS growth (TTM YoY) | -4.1%
11th
|
120.3%
100th
|
17.2%
33rd
|
| EPS CAGR, 3 yr | 7.5%
11th
|
54.1%
89th
|
174.9%
100th
|
| EPS CAGR, 5 yr | 7.6%
33rd
|
12.9%
67th
|
14.9%
78th
|
| FCF growth (TTM YoY) | 14.6%
60th
|
58.7%
100th
|
27.6%
70th
|
| FCF CAGR, 3 yr | 6.6%
20th
|
27.0%
80th
|
58.9%
100th
|
| Operating cash flow CAGR, 3 yr | 8.4%
20th
|
16.1%
70th
|
36.7%
100th
|
| Book value CAGR, 3 yr | 10.4%
78th
|
3.6%
44th
|
-2.4%
0th
|
| Dividend CAGR, 3 yr | — | 20.5%
100th
|
5.6%
88th
|
| Sustainable growth rate | 17.6%
75th
|
14.9%
62nd
|
26.1%
88th
|
Margin history & stability
7 measures| Measure | FDS | TRU | MORN |
|---|---|---|---|
| Gross margin, 3-yr average | 52.5%
20th
|
57.0%
30th
|
61.3%
40th
|
| Operating margin, 3-yr average | 30.8%
50th
|
15.3%
0th
|
20.9%
30th
|
| Net margin, 3-yr average | 23.9%
40th
|
8.1%
0th
|
15.0%
10th
|
| FCF margin, 3-yr average | 27.7%
30th
|
12.5%
0th
|
18.0%
10th
|
| Revenue stability (0-1) | 0.97
50th
|
0.99
80th
|
1.00
100th
|
| Earnings stability (0-1) | 0.78
80th
|
0.01
10th
|
0.42
50th
|
| Margin stability (0-1) | 0.97
80th
|
0.92
40th
|
0.97
70th
|
Liquidity (latest quarter)
7 measures| Measure | FDS | TRU | MORN |
|---|---|---|---|
| Cash & short-term investments | $265.3M
10th
|
$839.1M
40th
|
$523.8M
30th
|
| Net cash (− = net debt) | −$1.3B
70th
|
−$4.8B
50th
|
−$1.4B
60th
|
| Working capital | −$437.6M
10th
|
$1.0B
70th
|
$54.6M
40th
|
| Current ratio | 0.60
10th
|
1.90
90th
|
1.06
60th
|
| Quick ratio | 0.60
20th
|
1.90
90th
|
1.06
60th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.24
30th
|
0.73
70th
|
0.53
60th
|
| Defensive interval (days) | 374 days
20th
|
417 days
30th
|
338 days
10th
|
Leverage & solvency (latest quarter)
13 measures| Measure | FDS | TRU | MORN |
|---|---|---|---|
| Total debt | $1.5B
10th
|
$5.7B
40th
|
$1.9B
20th
|
| Debt / equity | 0.77
56th
|
1.17
78th
|
1.86
89th
|
| Net debt / equity | 0.64
67th
|
1.00
78th
|
1.35
89th
|
| Debt / assets | 37.2%
60th
|
46.4%
70th
|
48.3%
80th
|
| Debt / capital | 43.5%
56th
|
53.9%
78th
|
65.0%
89th
|
| Debt / EBITDA | 1.69
22nd
|
3.09
89th
|
2.35
56th
|
| Net debt / EBITDA | 1.40
22nd
|
2.63
78th
|
1.70
56th
|
| Interest coverage (EBIT / interest) | 8.6x
44th
|
4.9x
11th
|
11.5x
67th
|
| Cash interest coverage | 10.1x
44th
|
4.4x
0th
|
12.1x
56th
|
| Debt payback (years of OCF) | 1.9 yrs
20th
|
5.1 yrs
100th
|
2.9 yrs
60th
|
| Liabilities / assets | 51.7%
30th
|
59.0%
50th
|
74.1%
60th
|
| IS credit model rating | A- | A+ | A |
| Implied credit spread (bps) | 175
70th
|
125
20th
|
150
50th
|
Efficiency
11 measures| Measure | FDS | TRU | MORN |
|---|---|---|---|
| Asset turnover | 0.59
80th
|
0.42
60th
|
0.68
100th
|
| Fixed asset turnover | 12.86
40th
|
14.40
70th
|
6.35
10th
|
| Inventory turnover | — | — | — |
| Receivables turnover | 8.7
70th
|
4.8
20th
|
6.7
40th
|
| Days sales outstanding | 42 days
30th
|
76 days
80th
|
55 days
60th
|
| Days inventory outstanding | — | — | — |
| Days payables outstanding | 40 days
60th
|
63 days
80th
|
34 days
50th
|
| Cash conversion cycle (days) | 2 days
33rd
|
13 days
44th
|
20 days
78th
|
| Capex / revenue | 4.6%
67th
|
6.4%
100th
|
5.8%
89th
|
| Capex / depreciation | 0.54
89th
|
0.52
78th
|
0.75
100th
|
| Operating expense ratio | 23.9%
20th
|
26.5%
50th
|
39.7%
80th
|
Cash flow & earnings quality
7 measures| Measure | FDS | TRU | MORN |
|---|---|---|---|
| Operating cash flow / net income | 1.54
100th
|
1.30
67th
|
1.53
89th
|
| FCF / net income | 1.33
100th
|
0.93
11th
|
1.18
67th
|
| FCF / operating cash flow | 86.0%
22nd
|
71.4%
0th
|
76.9%
11th
|
| Capex / operating cash flow | 14.0%
78th
|
28.6%
100th
|
23.1%
89th
|
| Accruals ratio | -6.8%
10th
|
-2.2%
50th
|
-5.9%
20th
|
| Sloan accruals ratio | -20.3%
10th
|
-4.6%
50th
|
-7.0%
40th
|
| Earnings quality score (0-1) | 0.75
0th
|
1.00
33rd
|
0.75
0th
|
Scores & forensic checks
15 measures| Measure | FDS | TRU | MORN |
|---|---|---|---|
| IS score | 66
50th
|
69
60th
|
69
70th
|
| IS profitability | 77
60th
|
74
40th
|
78
70th
|
| IS growth | 39
20th
|
67
80th
|
52
30th
|
| IS value | 50
30th
|
58
70th
|
65
100th
|
| IS momentum | 68
20th
|
92
100th
|
78
40th
|
| IS risk (safety) | 100
10th
|
100
10th
|
100
10th
|
| IS quality | 79
50th
|
81
80th
|
73
10th
|
| IS balance sheet | 56
60th
|
48
40th
|
52
50th
|
| IS earnings quality | 74
50th
|
74
60th
|
73
30th
|
| IS cash flow | 79
80th
|
67
10th
|
72
20th
|
| Piotroski F-score (0-9) | 5
10th
|
8
80th
|
6
30th
|
| Altman Z-score | — | — | — |
| Beneish M-score | — | — | — |
| Ohlson O-score | −7.92
50th
|
−7.93
40th
|
−6.47
90th
|
| IS credit score | 69
30th
|
76
60th
|
73
40th
|
Size (TTM)
8 measures| Measure | FDS | TRU | MORN |
|---|---|---|---|
| Market cap | $10.7B
20th
|
$14.2B
30th
|
$7.8B
10th
|
| Revenue | $2.5B
10th
|
$4.9B
40th
|
$2.6B
20th
|
| EBITDA | $915.4M
30th
|
$1.8B
40th
|
$812.1M
20th
|
| Net income | $533.5M
30th
|
$847.9M
40th
|
$421.6M
20th
|
| Free cash flow | $707.5M
20th
|
$787.9M
30th
|
$497.5M
10th
|
| Total assets | $4.1B
20th
|
$12.2B
40th
|
$3.9B
10th
|
| Shareholders' equity | $2.0B
30th
|
$4.8B
50th
|
$1.0B
20th
|
| Employees | 12,694
60th
|
13,500
80th
|
10,973
50th
|
Price performance
9 measures| Measure | FDS | TRU | MORN |
|---|---|---|---|
| 1 day | −0.1% | −0.1% | −0.9% |
| 1 week | +5.0% | +13.1% | +1.4% |
| 1 month | +8.2% | +1.3% | +2.5% |
| 3 months | +18.4% | −6.2% | +20.7% |
| 6 months | +30.8% | −5.3% | +12.5% |
| Year to date | +7.3% | −11.0% | −1.4% |
| 1 year | +8.1% | −6.6% | −5.6% |
| 3 years, cumulative | −31.5% | +4.5% | −10.3% |
| 5 years, cumulative | −20.6% | −33.2% | −22.1% |
Technicals
4 measures| Measure | FDS | TRU | MORN |
|---|---|---|---|
| RSI 14 | 62.8 | 60.4 | 58.7 |
| From 52-week high | −5.9% | −16.8% | −7.3% |
| From 52-week low | +65.3% | +21.5% | +46.6% |
| Beta | 0.77 | 1.57 | 1.02 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17